DK173552B1 - Anvendelse af prostaglandin-E1-derivater til fremstilling af farmaceutiske præparater til transkutan indgift - Google Patents

Anvendelse af prostaglandin-E1-derivater til fremstilling af farmaceutiske præparater til transkutan indgift Download PDF

Info

Publication number
DK173552B1
DK173552B1 DK198800775A DK77588A DK173552B1 DK 173552 B1 DK173552 B1 DK 173552B1 DK 198800775 A DK198800775 A DK 198800775A DK 77588 A DK77588 A DK 77588A DK 173552 B1 DK173552 B1 DK 173552B1
Authority
DK
Denmark
Prior art keywords
treatment
pge
prostaglandin
preparation
derivatives
Prior art date
Application number
DK198800775A
Other languages
Danish (da)
English (en)
Other versions
DK77588A (da
DK77588D0 (da
Inventor
Juergen C Froelich
Herbert Bippi
Original Assignee
Ratiopharm Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ratiopharm Gmbh filed Critical Ratiopharm Gmbh
Publication of DK77588D0 publication Critical patent/DK77588D0/da
Publication of DK77588A publication Critical patent/DK77588A/da
Application granted granted Critical
Publication of DK173552B1 publication Critical patent/DK173552B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK198800775A 1987-02-16 1988-02-15 Anvendelse af prostaglandin-E1-derivater til fremstilling af farmaceutiske præparater til transkutan indgift DK173552B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3704825 1987-02-16
DE19873704825 DE3704825A1 (de) 1987-02-16 1987-02-16 Prostaglandin e1-derivate als pharmazeutische wirkstoffe und diese verbindungen enthaltende arzneimittel insbesondere zur transkutanen anwendung

Publications (3)

Publication Number Publication Date
DK77588D0 DK77588D0 (da) 1988-02-15
DK77588A DK77588A (da) 1988-08-17
DK173552B1 true DK173552B1 (da) 2001-02-26

Family

ID=6321070

Family Applications (1)

Application Number Title Priority Date Filing Date
DK198800775A DK173552B1 (da) 1987-02-16 1988-02-15 Anvendelse af prostaglandin-E1-derivater til fremstilling af farmaceutiske præparater til transkutan indgift

Country Status (11)

Country Link
EP (1) EP0292643B1 (nl)
JP (1) JPS63246331A (nl)
AT (1) ATE80616T1 (nl)
AU (2) AU623336B2 (nl)
CA (1) CA1327359C (nl)
DE (2) DE3704825A1 (nl)
DK (1) DK173552B1 (nl)
ES (1) ES2043696T3 (nl)
GR (1) GR3005743T3 (nl)
HU (1) HU199687B (nl)
ZA (1) ZA881053B (nl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2939569A (en) * 1957-10-16 1960-06-07 Gay W Roach Cotton weighing machine
CN1084190C (zh) * 1993-02-03 2002-05-08 帝人株式会社 含有前列环素作为活性成分的外用皮肤治疗剂组合物
CA2133435A1 (en) * 1993-02-03 1994-08-04 Atsuo Hazato External skin treatment agent composition containing isocarbacyclins as active ingredient
US6007836A (en) * 1993-05-28 1999-12-28 Vericade, Inc. Transdermal vasodilator
FR2812190B1 (fr) * 2000-07-28 2003-01-31 Oreal Utilisation d'agonistes non prostanoiques des recepteurs des prostaglandines ep-2 et/ou ep-4 comme agent cosmetique permettant d'attenuer, de diminuer ou d'arreter la chute des cheveux et des poils
FR2812191B1 (fr) * 2000-07-28 2003-10-17 Oreal Utilisation d'agonistes du recepteur des prostaglandines e2 (ep-3) pour attenuer, diminuer ou stopper la pousse des cheveux et des poils dans des preparations cosmetiques
FR2812192B1 (fr) * 2000-07-28 2003-01-31 Oreal Utilisation d'antagonistes de recepteur des prostaglandines ep-3 comme agent cosmetique permettant d'attenuer, de diminuer ou d'arreter la chute des cheveux et des poils
FR2812193B1 (fr) * 2000-07-28 2003-10-24 Oreal Utilisation d'antagoniste des recepteurs des prostaglandines ep-2 et/ou ep-4 pour attenuer, diminuer ou stopper la pousse des cheveux et des poils dans des preparations cosmetiques
CA2520347A1 (en) 2003-04-02 2004-10-21 Nexmed Holdings, Inc. Prostaglandin compositions and their use for the treatment of vasospasm
IT1402047B1 (it) * 2010-10-19 2013-08-28 Cross Pharma Sa Uso del mexiprostil nel trattamento delle malattie infiammatorie intestinali
JP2014510156A (ja) * 2011-04-07 2014-04-24 ネクスメッド ホールディングス，インコーポレイテッド レイノー病を治療する方法および組成物
US8865685B2 (en) 2011-06-30 2014-10-21 Johnson & Johnson Vision Care, Inc. Esters for treatment of ocular inflammatory conditions
ITRM20120036A1 (it) * 2012-02-02 2013-08-03 Robert Davis Steigerwalt Jr Applicazione transdermica di prostaglandina e1 per il trattamento dell¿ischemia oculare.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3735005A (en) * 1970-08-19 1973-05-22 Alza Corp Method for preparing a viable platelet concentrate
AU511711B2 (en) * 1976-12-30 1980-09-04 Upjohn Company, The 6-Oxo and 5, 6-Dihalo prostaglandin analogues
US4205178A (en) * 1976-12-30 1980-05-27 The Upjohn Company 6-Keto prostaglandin E-type compounds
JPS6022710B2 (ja) * 1977-09-16 1985-06-03 小野薬品工業株式会社 プロスタグランジン類似化合物
JPS59216820A (ja) * 1983-05-20 1984-12-06 Taisho Pharmaceut Co Ltd プロスタグランジン脂肪乳剤
US4707495A (en) * 1985-10-28 1987-11-17 Ortho Pharmaceutical Peptic ulcer treatment method

Also Published As

Publication number Publication date
AU1176688A (en) 1988-08-18
ES2043696T3 (es) 1994-01-01
AU649130B2 (en) 1994-05-12
ZA881053B (en) 1988-08-12
EP0292643A1 (de) 1988-11-30
DE3704825A1 (de) 1988-08-25
AU623336B2 (en) 1992-05-14
CA1327359C (en) 1994-03-01
ATE80616T1 (de) 1992-10-15
HU199687B (en) 1990-03-28
GR3005743T3 (nl) 1993-06-07
DK77588A (da) 1988-08-17
EP0292643B1 (de) 1992-09-16
JPS63246331A (ja) 1988-10-13
AU1518492A (en) 1992-06-25
DE3874610D1 (nl) 1992-10-22
HUT46224A (en) 1988-10-28
DK77588D0 (da) 1988-02-15

Similar Documents

Publication Publication Date Title
US5219885A (en) Prostaglandin E1 derivatives as pharmaceutically active agents, and pharmaceutical compositions containing these compounds, especially for transcutaneous administration
DK173552B1 (da) Anvendelse af prostaglandin-E1-derivater til fremstilling af farmaceutiske præparater til transkutan indgift
CA2562614C (en) Use of treprostinil to treat neuropathic diabetic foot ulcers
DE69118028T2 (de) Neue 2,6-Dialkyl-4-silyl-phenole als antiatherosclerotische Mittel und als Antioxidantien
US5153222A (en) Method of treating pulmonary hypertension with benzidine prostaglandins
JP3701870B2 (ja) 末梢血管疾患治療のための９−デオキシ−２’，９−α−メタノ−３−オキサ−４，５，６−トリノール−３，７−（１’，３’−インターフェニ
KR101466980B1 (ko) 위장 장애 치료를 위한 프로스타글란딘 화합물과 양성자펌프 억제제의 병용
EP2175861B1 (en) Pharmaceutical combination of naproxen with 13,14-dihydro-15-keto-16,16-difluoro-18-methyl-prostaglandin E1
TWI384988B (zh) 處理中樞神經系統失常用之組成物
TWI324589B (en) Halogenated bioactive lipid compound
KR20010108316A (ko) Ｃ16 불포화된 ｆｐ-선택적 프로스타글란딘 유사체
AU2139600A (en) Method and composition for treatment of female sexual dysfunction
JPS58198467A (ja) 新規プロスタグランデイン誘導体類
US5510382A (en) Method for composition for treatment of gastric and duodenal disorders
KR101360579B1 (ko) 신규 페닐초산 유도체
CA2180010C (en) 7-[carboxyalkyl or alkenyl]-6-[alkyl or alkenyl] 3-oxo-2,4-dioxobicyclo-[3.2.1] octane and derivatives thereof
JP2550176B2 (ja) イソカルバサイクリン誘導体を活性成分として含有する糖尿病性神経症治療剤
JP2522962B2 (ja) 乾癬治療剤
JPS6144819A (ja) プロスタグランジンｉ２類縁化合物を含有する循環改善作用を有する薬剤
NO157329B (no) Analogifremgangsmaate for fremstilling av 5-fluor pgi-forbindelser.
TW205508B (nl)
EP0402477B1 (en) Use of isocarbacyclins for preventing or treating organ diseases
JP2001097866A (ja) 抗ヘリコバクター・ピロリ剤
US5364883A (en) Isocarbocyclins for the treatment of liver and kidney diseases
GB2025972A (en) 20-methyl-13, 14-didehydro- PGl2 derivatives and process for their preparation

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK